| Literature DB >> 32183224 |
Marta Sánchez1, Elena González-Burgos1, Irene Iglesias1, M Pilar Gómez-Serranillos1.
Abstract
Aloe vera has been traditionally used to treat skin injuries (burns, cuts, insect bites, and eczemas) and digestive problems because its anti-inflammatory, antimicrobial, and wound healing properties. Research on this medicinal plant has been aimed at validating traditional uses and deepening the mechanism of action, identifying the compounds responsible for these activities. The most investigated active compounds are aloe-emodin, aloin, aloesin, emodin, and acemannan. Likewise, new actions have been investigated for Aloe vera and its active compounds. This review provides an overview of current pharmacological studies (in vitro, in vivo, and clinical trials), written in English during the last six years (2014-2019). In particular, new pharmacological data research has shown that most studies refer to anti-cancer action, skin and digestive protective activity, and antimicrobial properties. Most recent works are in vitro and in vivo. Clinical trials have been conducted just with Aloe vera, but not with isolated compounds; therefore, it would be interesting to study the clinical effect of relevant metabolites in different human conditions and pathologies. The promising results of these studies in basic research encourage a greater number of clinical trials to test the clinical application of Aloe vera and its main compounds, particularly on bone protection, cancer, and diabetes.Entities:
Keywords: Aloe vera; extracts; isolated compounds; pharmacology
Mesh:
Substances:
Year: 2020 PMID: 32183224 PMCID: PMC7144722 DOI: 10.3390/molecules25061324
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
In vitro pharmacological studies for Aloe vera.
| Experimental Model | Major Findings | References | |
|---|---|---|---|
| Digestive Diseases Protection | |||
| Acemannan | Human deciduous pulp cells | ↑ Pulp cell proliferation | [ |
| HT-29 cells LPS and TNF-α induced | ↑ JAK2 and STAT-3 expression | [ | |
| Dental pulp stem cells from rabbits | ↑ Cell viability | [ | |
| Skin Protection | |||
| HaCaT cells | ↓ TNF-α levels | [ | |
|
| HEKa and NFDH cells | ↑ Cell viability | [ |
|
| HaCaT cells | ↓ Photodamage | [ |
| c147 cells | ↑ Fibroblast migration | [ | |
| Mouse embryonic fibroblast cells | ↑ TFGβ1 and bFGF factor expression | [ | |
| HEKa | ↑ Cell number | [ | |
| Aloesin | HaCaT cells | ↑ Cell migration | [ |
| Aloin | Hs 68 cells | ↑ GSH | [ |
| Aloin | κβ cells | ↓ IL-8 production | [ |
| Emodin | THP-1 cells and HaCaT cells | ↑ VEGF | [ |
| Pure | Primary cultures of corneal epithelial cells and fibroblasts | ↑ Corneal epithelial cell wound closure ( | [ |
| Anti-Inflammatory Activity | |||
| Acemannan | Human gingival fibroblasts | ↑ IL-6 and IL-8 expression | [ |
| Peripheral blood mononuclear cells | ↓ CD25 and CD28 expression | [ | |
| Aloe-emodin sulfates/glucuronides, rhein sulfates/glucuronides, aloe-emodin and rhein | RAW 264.7 cells stimulated with LPS and mouse peritoneal excluded macrophages | ↓ iNOS expression | [ |
| Aloin | RAW 264.7 cells | ↓ iNOS expression | [ |
| Aloin | KB cells | ↓Salivary IL-1β-induced IL-8 production | [ |
| Barbaloin/aloin | RAW 264.7 cells stimulated with LPS | ↓ Phosphorylation levels of IκBα and NF-κB p65 | [ |
| Anticancer Effects | |||
| Aloe polysaccharide | BxPC-3 cells | ↑ ULK1 mRNA expression | [ |
| MCF-7 cells and HeLa cells | ↓ Cell viability | [ | |
| Aloe-emodin | Metastatic human melanoma cell lines | ↓ Cell proliferation | [ |
| Aloe-emodin | TE1 cancer cells | ↓ AKT and ERK phosphorylation | [ |
| Aloe-emodin | MCF-7 cells | ↓ Adhesion, migration and invasion of cells | [ |
| Aloe-emodin | HUVECs cells | ↓ Angiogenesis and Cell Metastasis | [ |
| Aloe-emodin | SW620 and HT29 cells | ↓ Cell viability | [ |
| Aloe-emodin | HeLa cells | ↓ Cell proliferation | [ |
| Aloe-emodin | MG-63 cells | ↑ ROS production | [ |
| Aloe-emodin | HeLa cells | ↑ Mitotic death | [ |
| Aloe-emodin | Breast cancer cells (MCF-7, MDA-MB-231, MDA-MB-468, BT-474, HCC-1954) | ↑ Tamoxifen cytotoxicity | [ |
| Aloe-emodin | MG-63 cells | ↓ Cell viability | [ |
| Aloesin | SKOV3 cells | ↓ Cell viability | [ |
| Emodin | KB cells | ↓ Cell proliferation | [ |
| Antidiabetic Effect | |||
| Hamster pancreatic β-cell line HIT-T15 in response to free fatty acids | ↓ Number of apoptotic β-cell death | [ | |
| Aloe-emodin | RIN-5F cells | ↑ Cell viability | [ |
| Antioxidant Properties | |||
| In vitro antioxidant methods: DPPH, metal chelating, hydrogen peroxide scavenging, reducing power and β-carotene-linoleic | Antioxidant activity | [ | |
| Cell models (HeLa, HMEC, HaCat, and HOS) hydrogen peroxide and 4-hydroxynonenal induced | ↓ ROS production | [ | |
| Anthraquinone derivatives | Peroxyl radical scavenging | Antioxidant activity | [ |
| Bone Protection | |||
| Aloe-emodin | ATDC5 cells | ↑ Accumulation cartilage nodules | [ |
| Aloin | RAW 264.7 cells | ↓ RankL induced miR-21 expression | [ |
| Aloin | RAW264.7 cells | ↓ TRAP content | [ |
| Cardioprotective EFFECT | |||
| Aloe emodin | Model heme protein (hemoglobin) | ↓ Hemoglobin aggregation (máximum effect at 100 μM) | [ |
| Antimicrobial and Prebiotic Activity | |||
| Acemannan and fructans | ↑ Bacterial growth (fructans) | [ | |
| H1N1 subtype Influenza A virus | ↓ H1N1 subtype influenza virus replication | [ | |
| Methicillin resistant | ↓ Growth | [ | |
| Drug resistant | Inhibition zone: 60 mm (disk diffusion method) | [ | |
|
| Antiplasmodial activity | [ | |
| Multidrug-resistant | Similar MIC50 and MIC90 | [ | |
| Antibacterial activity against oral pathogens | [ | ||
| Virus herpes simplex 1 | ↓ HSV-1 growth | [ | |
|
| Antibacterial activity against | [ | |
| Gram negative bacteria, Gram positive bacteria and | Antimicrobial and antibiofilm activities against Gram negative bacteria ( | [ | |
| Intestinal microbiota from healthy donors | Prebiotic activity (↑ short chain fatty acids and modifications in bacterial composition) | [ | |
| Aloe-emodin |
| ↓ Biofilm development (initial adhesion and proliferation stages) and extracellular protein production | [ |
| Other Effects | |||
| Aloe-emodin | MH7A human RA synovial fibroblast-like cells | ↓ Viable cells number | [ |
| Aloe-emodin | ARPE-19 cells | ↓ VEGF secretion | [ |
In vivo pharmacological studies for Aloe vera.
| Experimental Model | Major Findings | References | |
|---|---|---|---|
| Digestive Diseases Protection | |||
| Acemannan | Beagle Dogs | Mineralized Bridge Formation | [ |
| 2,4,6-three nitrobenzene sulfonic acid colitis induced | ↑ JAK2, p-JAK2, STAT-3 and p-STAT3 protein expression | [ | |
| Balb/c mouse model of alcohol-induced acute gastritis | ↑ Matrix metalloproteinase-9 inhibitory activity | [ | |
|
| Male Wistar rats | ↑ Salivary flow rate | [ |
| Skin Protection | |||
| Aloe emodin | BALB/c mice burn wound-induced | ↑ Wound healing activity (↑ re-epithelialization and angiogenesis) | [ |
| Aloe sterols | Female HR-1 hairless mice | ↓ Skin dryness, epidermal thickness and wrinkle formation | [ |
|
| Adult male Wistar rats with incision on neck | ↑ Fibroblasts | [ |
|
| Adult female Sprague Dawley rats with a skin wound infected with methicillin-resistant | ↓ Inflammatory cell infiltration | [ |
| X-ray irradiated Male balb/c mice | ↑ Hepatic and renal function parameters | [ | |
| Male Sprague-Dawley rats | ↓ Wound percentage | [ | |
| Wistar rats with a wound made by incision | ↑ Organization of skin and collagen | [ | |
| Male Wistar rats | ↓ Necrotic tissue and inflammation | [ | |
| Male Wistar rats | ↑ Wound contraction and epithelialization | [ | |
| X-ray irradiated Male balb/c mice | ↑ Hepatic and renal function parameters | [ | |
| Ovariectomy HR-1 hairless mice | ↓ Matrix metalloproteinases (MMPs) expression | [ | |
| HR-1 hairless mice | ↑ Skin elasticity | [ | |
| Wistar rats with traumatic ulcers | No acceleration of oral wound | [ | |
| Aloesin | SKH-1 hairless mice | ↑ Angiogenesis | [ |
| Anti-Inflammatory Activity | |||
|
| Male ICR strain mice | ↓ Hepatic MDA | [ |
| Aloe-emodin sulfates/glucuronides, rhein sulfates/glucuronides, aloe-emodin and rhein | LPS-induced septic mice | ↓ NO level | [ |
| Barbaloin | BALB/c mice LPS-induced acute lung injury | Histological analysis revealed certain protective effect | [ |
| Anticancer Effects | |||
| Male Swiss albino mice | Mutagenic activity | [ | |
| Mice with breast cancer by implantind | ↓ COX-2 level | [ | |
| C57BL/6J mice high-fat diet induced and azoxymethane induced aberrant crypt foci colorectal cancer | ↑ Hepatic phase II enzyme glutathione S-transferase mRNA levels | [ | |
| BALB/c female mice with induced colitis-associated colon carcinogenesis | ↓ Multiplicity of colonic adenomas and adenocarcinomas | [ | |
| Aloesin | Mice | ↓ Tumor growth | [ |
| Aloin | Male Swiss albino rats | ↑ Erythropoiesis impairment | [ |
| Emodin | SPF BALB/c-nu nude mice | ↑ Survival time of tumor | [ |
| Antidiabetic Effect | |||
| Streptozotocin-induced diabetic Wistar rats | ↓ Blood glucose levels | [ | |
| Streptozotocin-induced nephropathy diabetic Wistar rats | ↓ Development of nephropathy | [ | |
| Streptozotocin-induced diabetic male Wistar rats | ↓ Anxiety/depression-like behaviors | [ | |
| Wistar rats with corneal alkali-burn injury | ↑ Wound healing (especially in diabetic rats) | [ | |
| C57BL/KsJ-db/db male mice fed with high fat diet | ↓ Fasting blood glucose levels | [ | |
| Cardioprotective Effect | |||
|
| Wistar albino rats | ↓ MDA levels | [ |
| Wistar Albino rats with ischemia—reperfusion injury of sciatic nerve | ↓ Ischemic fiber degeneration | [ | |
| Male Wistar albino rats | ↑ SOD, CAT and GPx | [ | |
| Male Wistar Albino rats | ↓ Ischemic fiber degeneration | [ | |
| Aloe-emodin | Male Wistar rats | ↓Total cholesterol | [ |
| Aloe-emodin | Sprague Dawley rats | ↓Hypoxia-induced retinal neovascularization | [ |
| Aloin | Swiss albino rats | ↓ Triacylglycerols | [ |
| Barbaloin/aloin | Sprague-Dawley rats | ↓ I/R induced myocardial oxidative stress and inflammatory response | [ |
| Antimicrobial and Prebiotic Activity | |||
| PR8(H1N1) virus infection SPF BALB/c mice | Clinical symptoms improvement | [ | |
| Other Effects | |||
| Female Wistar albino rats | ↓ Agitation, disparity and floppy eyelids | [ | |
| Wistar rats drug-induced sleeping and anesthesia and analgesia | ↑ Loss of righting reflex | [ | |
| Wistar rats | ↑ Mounting frequency | [ | |
| Rats | ↓ TNF-α levels | [ | |
| C57BL/6 female mice | ↑ Lymphocyte and erythrocytes number | [ | |
| Wistar rats Bisphenol A Induced Testicular Toxicity | ↑ Body and testis weights | [ | |
| Balb/c mice pulmonary tissue of cigarette smoke induced | ↓ Degree of histoarchitectural alterations | [ | |
| Wistar rats with partial transection of the calcaneal tendon | ↑ Non-collagenous proteins | [ | |
| Albino rabbits | Normalized levels of white blood cells, red blood cells, platelet count, packed cell volume, mean cell volume and haemoglobin values | [ | |
| Wistar rats | ↓ Testes weight | [ | |
| BALB/c mice on ovalbumin -induced food allergy | ↓ Serum concentrations of type 2 helper T cell (Th2) cytokines (Interleukin-(IL)-4, IL-5, and IL-13) | [ | |
| Aloin | F344/N Rats | ↑ Incidences and severities of mucosal and goblet cell hyperplasia | [ |
Clinical trials with Aloe vera.
| Reference | Study Design | Number of Patients | Intervention | Results |
|---|---|---|---|---|
| Digestive Diseases Protection | ||||
| Anuradha et al. (2017) | - | 74 | Group 1: | Oral submucous fibrosis: |
| Ashouri Moghaddam et al. (2017) | Single-blind clinical trial | 20 | Group 1: | Chronic periodontitis: |
| Fallahi et al. (2016) | Randomized double blind | 20 | Group 1: | ↓ Swelling |
| Gupta et al. (2014) | Double blind randomized control trial | 300 | Group 1: | ↓ Plaque index and gingival index |
| Ipshita et al. (2018) | - | 90 | Group 1: Placebo | Chronic periodontitis: |
| Kalra et al. (2017) | - | 48 | Group 1: | Pulpotomy: Success rates was higher in mineral trioxide aggregate than in |
| Kurian et al. (2018) | Randomized, single-center, longitudinal, triple-blinded, parallel arm y | 90 | Group 1: Placebo | Chronic periodontitis: |
| Mansouri et al. (2016) | Randomized controlled clinical trial | 64 | Group 1: | Stomatitis: ↓ Chemotherapy-induced Stomatitis in patients with lymphoma and leukemia |
| Nimma et al. (2017) | Cross-sectional randomized interventional study | 40 | Group 1: analgesics (7 days) and socket healing | Ulcers: |
| Panahi et al. (2015) | Pilot, randomized controlled, open-label, trial | 79 | Group 1: | ↓ Frequency symptoms gastroesophageal reflux disease |
| Prabhakar et al. (2015) | Experimental, in vivo intergroup split mouth, randomized clinical trial | 10 | Group 1: Distilled water | Antimicrobial: |
| Pradeep et al. (2016) | Single center, randomized, longitudinal, triple masked, interventional study | 60 | Group 1: Placebo | Chronic periodontitis: |
| Rahmani et al. (2014) | Prospective observational clinical trial | 60 | Cream of 0.5% | ↓ Chronic anal fissure pain and hemorrhaging upon defection |
| Sahebjamee et al. (2015) [ | Triple-blind randomised and controlled interventional | 26 | Group 1: | Oral mucositis: ↓ Severity of radiation-induced mucositis in patients with head and neck cancers |
| Sahebnasagh et al. (2017) [ | Double-blind placebo-controlled trial | 20 | Group 1: | Proctitis: Improvement of diarrhea, fecal urgency, clinical presentation total, Radiation Therapy Oncology Group total and lifestyle |
| Singh et al. (2016) | - | 40 | Group 1: | Oral submucous fibrosis: |
| Størsrud et al. (2015) | Randomized, double-blind, placebo controlled study | 68 | Group 1: | Irritable bowel syndrome: ↓ severity of the gastrointestinal symptoms |
| Vangipuram et al. (2016) | Randomized controlled trial | 390 | Group 1: | Gingivitis: |
| Yeturu et al. (2016) | Randomized single-center, single-blind, parallel group, controlled trial | 85 | Group 1: | ↓ Mean plaque and gingival scores |
| Skin Protection | ||||
| Ahmadloo et al. (2017) | Prospective randomized controlled clinical trial | 100 | Group 1: | Dermatitis: No positive effect on prevalence or severity of radiation dermatitis |
| Avijgan et al. (2016) | - | 60 | Group 1: | Ulcers: wound healing |
| Burusapat et al. (2018) | Double-blind, randomized, controlled trial | 12 | Group 1: | ↑ Split-thickness skin graft donor-site healing |
| Hekmatpou et al. (2018) | Triple-blind randomized clinical trial | 80 | Group 1: pure | Ulcers: ↓ pressure ulcers |
| Hoopfer et al. (2015) | Three-Arm Randomized Phase III Trial | 248 | Group 1: | No ↓ skin reaction severity in breast cancer radiation therapy |
| Irani and Varaie (2016) | Randomized clinical trial | 30 | Burned area: nitrofurazone 2% | Burns: Earlier epithelialization and granulation tissue |
| Molazem et al. (2014) | Prospective randomized double-blind clinical trial | 90 | Group 1: | ↑ Cesarean wound healing |
| Tanaka et al. (2015) | Randomized, double-blind, placebo-controlled study | 58 | Group 1: | ↓ Facial wrinkles |
| Tanaka et al. (2016) | Randomized, double-blind, placebo-controlled study | 48 | Group 1: | ↑ Skin elasticity in photodamaged skin |
| Tanaka et al. (2016) | Randomized, double-blind, placebo-controlled study | 64 | Group 1: | ↑ Gross elasticity, net elasticity, biological elasticity, skin fatigue area, collagen content |
| Anticancer Effects | ||||
| Damani et al. (2015) | Case report | 1 | Ocular surface squamous neoplasia: Lesion regressed | |
| Koo et al. (2019) | Randomized | 40 | Group 1: | Cancer: |
| Antidiabetic Effect | ||||
| Alinejad-Mofrad et al. (2015) [ | Double blind randomized controlled trial | 72 | Group 1: Placebo | Diabetes: |
| Antioxidant Properties | ||||
| Prueksrisakul et al. (2015) [ | - | 53 | Antioxidant: | |
| Cardioprotective Effect | ||||
| Alinejad-Mofrad et al. (2015) [ | Double blind randomized controlled trial | 72 | Group 1: Placebo | ↓ HbA1C (AL300, 8 weeks) |
| Antimicrobial and Prebiotic Activity | ||||
| Prueksrisakul et al. (2015) [ | - | 53 | Antimicrobial: | |
Figure 1Chemical structure of compounds isolated from Aloe vera with pharmacological activity.
Figure 2Pharmacological effects of the main constituents of Aloe vera.